摘要
在生物传感领域,分析技术的发展主要集中在对生物活性物种的监测方面,特别是在实时分析方面。本文综述了电化学酪氨酸酶生物传感器在药物分析中的应用,也称为生物标志物。首先,重点介绍了酪氨酸酶的性质、用各种电化学传感器解释酪氨酸酶的反应机理以及在传感器表面稳定固定这种生物催化剂所需的技术。在这种情况下,安培传感器代表了最常用的电化学传感类型,因为它们通常提供敏感的电流响应对样品中的分析物的存在。许多科学工作表明,这些极具选择性的生物分析设备可用于各种严重疾病的临床诊断,因为它们是诊断神经退行性疾病、检测负责食源性疾病的微生物病原体和诊断细胞病理学(尤其是黑色素瘤)的有效分析工具。此外,还开发了各种电化学酪氨酸酶生物传感器,用于测定其他对人体代谢、药物及其代谢产物、多种激素、氨基酸和蛋白质具有重要作用的酶的催化活性。尽管酪氨酸酶生物传感器具有诸多优点,但由于其使用寿命相对较短,不能超过一个月,因此仍未在常规的实验室实践中使用。模拟酪氨酸酶活性位点的催化聚合物的不断发展可能是解决这一严重缺陷的途径之一。
关键词: 生物传感器,酪氨酸酶,电分析,医学,诊断,生物标志物。
Current Medicinal Chemistry
Title:Tyrosinase Electrochemical Biosensors Monitoring Medicinally Significant Substances
Volume: 25 Issue: 33
关键词: 生物传感器,酪氨酸酶,电分析,医学,诊断,生物标志物。
摘要: Nowadays in biosensing, development of analytical techniques is focused on improvement for monitoring biologically active species in living organisms, especially in real-time analysis. This article provides an overview of applications of electrochemical tyrosinase biosensors in the analysis of medicinally significant substances, also known as biomarkers. At the beginning, special attention is paid to characterisation of the tyrosinase enzyme, explanation of reaction mechanisms of tyrosinase with various types of electrochemical transducers and techniques needed for stable immobilization of this biocatalyst on the transducer surface used. In this case, amperometric transducers represent the most frequently used type of electrochemical sensing because they usually provide sensitive current response to the presence of analyte in the sample. Many scientific works suggest that these very selective bioanalytical devices could find application in the clinical diagnosis of various serious diseases because they represent the effective analytical tools for diagnosis of neurodegenerative disorders, detection of microbial pathogens responsible for foodborne illness and diagnosis of cytopathology, especially melanoma cancer. Additionally, various kinds of electrochemical tyrosinase biosensors are presented which were developed to determine the catalytic activity of other enzymes significant for human metabolism, medicaments and their metabolic products, several hormones, amino acids and proteins. Despite all of their advantages, it is necessary to state that tyrosinase biosensors are still not used in the routine laboratory practice due to their relatively short service life which is not longer than one month unfortunately. Never-ending development of catalytic polymers imitating the tyrosinase active site could be one of ways to solve this serious drawback.
Export Options
About this article
Cite this article as:
Tyrosinase Electrochemical Biosensors Monitoring Medicinally Significant Substances, Current Medicinal Chemistry 2018; 25 (33) . https://dx.doi.org/10.2174/0929867324666170727121327
DOI https://dx.doi.org/10.2174/0929867324666170727121327 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design Fusogenic Oncolytic Herpes Simplex Viruses as a Potent and Personalized Cancer Vaccine
Current Pharmaceutical Biotechnology 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules
Mini-Reviews in Medicinal Chemistry Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
Current Medicinal Chemistry In vivo behavior and Safety of Lapatinib-Incorporated Lipid Nanoparticles
Current Pharmaceutical Biotechnology Erythropoiesis Stimulating Agents and Anaemia of End-Stage Renal Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine An Update on Developments in Female Hormonal Contraception
Current Women`s Health Reviews Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Overview of Proteasome Inhibitor-Based Anti-cancer Therapies: Perspective on Bortezomib and Second Generation Proteasome Inhibitors versus Future Generation Inhibitors of Ubiquitin-Proteasome System
Current Cancer Drug Targets Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications
Current Cancer Drug Targets Bioactive Secondary Metabolites from a Thai Collection of Soil and Marine-Derived Fungi of the Genera Neosartorya and Aspergillus
Current Drug Delivery Gene Therapy and Biologic Therapy with Interleukin?4
Current Gene Therapy Protein Kinase C and Oxidative Stress in an Animal Model of Mania
Current Neurovascular Research New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
Current Pharmaceutical Design New Insights into Chemistry and Anti-Infective Potential of Triazole Scaffold
Current Medicinal Chemistry Repurposing of Benzimidazole Scaffolds for HER2 Positive Breast Cancer Therapy: An <i>In-Silico</i> Approach
Current Drug Research Reviews Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets Genotoxicity of Nanocarriers
Current Drug Metabolism Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
Current Drug Metabolism